Amgen's Double-Knockout Mice Predicted To Inhibit Neurotoxic Etiology Of Alzheimer's Disease March 20, 2001
Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: February 2001 March 19, 2001
Often-Used CMV Vector Promoter Touched Off An Immune Backlash In Muscular Dystrophy Therapy March 19, 2001
RSS